The prolonged survival of human eosinophils with interleukin-5 and its inhibition by theophylline via apoptosis

Clinical and Experimental Allergy, Supplement

Volumn 26, Issue 2, 1996, Pages 10-15

  Ohta, K ^a   Sawamoto, S ^a   Nakajima, M ^a   Kubota, S ^a   Tanaka, Y ^a   Miyasaka, T ^a   Nagai, A ^b   Hirai, K ^c   Mano, K ^a   Miyashita, H ^a  

^a TEIKYO UNIVERSITY   (Japan)

^b TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; DEXAMETHASONE; DNA FRAGMENT; RECOMBINANT INTERLEUKIN 5; THEOPHYLLINE;

ADULT; APOPTOSIS; ASTHMA; CELL STRUCTURE; CLINICAL ARTICLE; CONFERENCE PAPER; EOSINOPHIL; EOSINOPHILIA; FEMALE; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL;

ADULT; APOPTOSIS; CELL SURVIVAL; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EOSINOPHILS; FEMALE; HUMANS; INTERLEUKIN-5; MALE; THEOPHYLLINE;

EID: 0029972691     PISSN: 09602178     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (18)

1. Wardlaw AJ, Dunnette S, Gleich GJ et al. Eosinophils and mast cells in bronchoalveolar lavage in subjects with mild asthma. Relationship to bronchial hyperreactivity. Am Rev Respir Dis 1988; 137:62-9.
2. Bousquet J, Chanez P, Lacoste JY et al. Eosinophilic inflammation in asthma. N Engl J Med 1990; 323:1033-9.
3. Gleich GJ. The eosinophil and bronchial asthma: current understanding. J Allergy Clin Immunol 1990; 85:422-36.
4. Yamaguchi Y, Hayashi Y, Sugama Y et al. Highly purified murine interleukin-5 (IL-5) stimulates eosinophil function and prolongs in vitro survival: IL-5 as an eosinophil chemotactic factor. J Exp Med 1988; 167:1737-42.
5. Yamaguchi Y, Suda T, Ohta S et al. Analysis of the survival of mature human eosinophils: Interleukin-5 prevents apoptosis in mature human eosinophils. Blood 1991; 78:2542-7.
6. Mitenko PA, Ogilvie RI. Rational intravenous doses of theophylline. N Engl J Med 1973; 289:600-3.
7. Lam A, Newhouse MT. Management of asthma and chronic airflow limitation. Are methylxanthines obsolete? Chest 1990; 98:44-52
8. Nassif EG, Weinburger M, Thompson R, Huntley W. The value of theophylline in steroid-dependent asthma. N Engl J Med 1981; 304:71-5.
9. Brenner MR, Berkowitz NM, Strunk RC. Need for theophylline in severe steroid-requiring asthmatics. Clin Allergy 1988; 18:143-50.
10. Wyllie AH. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 1980; 284:555-6.
11. Garther I. Separation of human eosinophils in density grandients of polyvinylpyrrolidone-coated silica gel (Percoll). Immunology 1980; 40:133-6.
12. Mishell BB, Shiigi SM. Determination of viability with fluorescein diacetate. In: Mishell BB, Shiigi SM, eds. Selected Methods in Cellular Immunology. San Francisco: WH Freeman, 1980: 19.
13. Nieto MA, Lopez-Rivas A. IL-2 protects T-lymphocytes from glucocorticoid-induced DNA fragmentation and death. J Immunol 1989; 143:4166-70.
14. Willie AH, Kerr JFR, Currie AR. Cell death. The significance of apoptosis. Int Rev Cytol 1980; 68:251-306.
15. Lopez AF, Sanderson CJ, Gamble JR et al. Recombinant human interleukin-5 is a selective activator of human eosinophil function. J Exp Med 1988; 167:219-24.
16. Hallsworth MP, Litchfield TM, Lee TH. Glucocorticoids inhibit granulocyte-macrophage colony-stimulating factor-1 and interleukin-5 enhanced in vitro survival of human eosinophils. Immunology 1992; 75:382-5.
17. Djukanovic R, Wilson JW, Britten YM et al. Effect of an inhaled corticosteroid on airway inflammation and symptoms of asthma. Am Rev Respir Dis 1992; 143:669-74.
18. Bergstrand H. Phosphodiesterase inhibition and theophylline. Eur J Respir Dis 1980; 61 (Suppl. 109):37-44.